Replies to post #98636 on Biotech Values

[tony111]

They have no intention of doing so. They are going for 2nd line since both Tasigna and Sprycel will become first line. 2nd line will make them enough money to have a head to head trial in the future. Berger should go solo IMO. I still think he messed up not raising some cash when the stock price is at 4.

[rkrw]

They're working on a partnership. What's your rush? They can't exactly move it to front line before it's approved for 2nd/3rd line.

[biomaven0]

I'm sure they will partner 534 at some point. But it's not crazy to wait until next year.

It's a tradeoff between getting better terms and starting trials sooner in other indications and for 2nd line.

Peter